Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 144 clinical trials for: 150 miles

Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • Recruiting
NCT07222566
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
  • Recruiting
NCT07160244
Sex: All
Age: 1 day - 49 years
Locations: 50
View study
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
  • Recruiting
NCT05623020
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
  • Recruiting
NCT07729462
Sex: All
Age: 18+
Locations: 19
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 233
View study
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
  • Recruiting
NCT06952660
Sex: Female
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
  • Recruiting
NCT07609914
Sex: All
Age: 18+
Locations: 21
View study
Recruiting
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
  • Recruiting
NCT06807281
Sex: All
Age: 2 - 11
Locations: 39
View study
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  • Recruiting
NCT06807268
Sex: All
Age: 6 - 11
Locations: 47
View study
...